Return
SynNotch-iNOS CAR-macrophages remodel the tumor immune microenvironment and exhibit antitumor efficacy via a CD4+ T cell-dependent mechanism
Y
Z
C
L
Q
J
S
DOI:10.1016/j.trsl.2026.06.017.png)
Abstract
En 中文
• Engineered synNotch-iNOS CAR-M enables antigen-triggered nitric oxide release. • CAR iNOS-M remodels the tumor immune microenvironment to inhibit solid tumors. • Antitumor efficacy is strictly dependent on CD4+ T cells but independent of CD8+ T cells. • CAR iNOS-M treatment reduces lung interstitial macrophages and PF4 levels. • Disruption of PF4 signaling inhibits Th1-Treg polarization and T-cell exhaustion.
Journal
IF:
5.9
Papers:
2.0K
Citations:
7.1K
